Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
Study reinforces generalizability of perioperative azithromycin for unplanned cesarean deliveries

Study reinforces generalizability of perioperative azithromycin for unplanned cesarean deliveries

New antibiotic kills drug-resistant bacteria by targeting a previously unknown vulnerability

New antibiotic kills drug-resistant bacteria by targeting a previously unknown vulnerability

What medicine-exposed rats reveal about the next urban zoonotic threat

What medicine-exposed rats reveal about the next urban zoonotic threat

Azithromycin fails to improve severe wheezing in preschool children

Azithromycin fails to improve severe wheezing in preschool children

Analyzing bacterial enzymes in pikromycin synthesis

Analyzing bacterial enzymes in pikromycin synthesis

Single-dose pill shows promise against antibiotic-resistant gonorrhoea

Single-dose pill shows promise against antibiotic-resistant gonorrhoea

Cystic fibrosis patients on triple-drug therapy can safely reduce daily lung treatments

Cystic fibrosis patients on triple-drug therapy can safely reduce daily lung treatments

Waning immunity and falling vaccination rates fuel pertussis outbreaks

Waning immunity and falling vaccination rates fuel pertussis outbreaks

Increasing resistance to key gonorrhea antibiotics raises alarm

Increasing resistance to key gonorrhea antibiotics raises alarm

Uganda’s most vulnerable region faces high Salmonella burden

Uganda’s most vulnerable region faces high Salmonella burden

App boosts antibiotic prescribing safety in outpatient clinics

App boosts antibiotic prescribing safety in outpatient clinics

Efficacy of methylprednisolone doses in severe Mycoplasma Pneumonia

Efficacy of methylprednisolone doses in severe Mycoplasma Pneumonia

Senegal becomes ninth African country to eliminate trachoma

Senegal becomes ninth African country to eliminate trachoma

Burundi eliminates trachoma and sets example for disease control in Africa

Burundi eliminates trachoma and sets example for disease control in Africa

When old diseases find new ways in: Europe’s latest diphtheria outbreak explained

When old diseases find new ways in: Europe’s latest diphtheria outbreak explained

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

New guidelines aim to improve diagnosis and treatment of mycoplasma pneumoniae in children

New guidelines aim to improve diagnosis and treatment of mycoplasma pneumoniae in children

Study shows decline in ambulatory antibiotic use in France following COVID-19 lockdown

Study shows decline in ambulatory antibiotic use in France following COVID-19 lockdown

Study reveals trends in drug-resistant Campylobacter infections across the U.S.

Study reveals trends in drug-resistant Campylobacter infections across the U.S.

Urban density and HIV prevalence linked to rising antibiotic resistance in gonorrhea

Urban density and HIV prevalence linked to rising antibiotic resistance in gonorrhea

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.